Genor Biopharma Holdings Ltd
HKEX:6998
Genor Biopharma Holdings Ltd
HKEX:6998
Price:
3.4
HKD
5.26%
Market Cap:
HK$6.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Genor Biopharma Holdings Ltd
HKEX:6998
|
CN |
|
A
|
Alternative Income REIT PLC
LSE:AIRE
|
UK |
|
Ying Hai Group Holdings Company Ltd
HKEX:8668
|
MO |
|
Sunstone Development Co Ltd
SSE:603612
|
CN |
|
Shanghai Yongguan Adhesive Products Corp Ltd
SSE:603681
|
CN |
Income Statement
Earnings Waterfall
Genor Biopharma Holdings Ltd
Genor Biopharma Holdings Ltd
Income Statement
Genor Biopharma Holdings Ltd
Genor Biopharma Holdings Ltd
Currency: CNY
| Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||
| Interest Expense |
0
|
6
|
0
|
2
|
1
|
3
|
2
|
1
|
0
|
0
|
0
|
0
|
|
| Revenue |
17
N/A
|
10
-38%
|
10
N/A
|
0
N/A
|
3
N/A
|
16
+439%
|
13
-19%
|
0
N/A
|
14
N/A
|
2 546
+17 495%
|
2 564
+1%
|
2 487
-3%
|
|
| Gross Profit | |||||||||||||
| Cost of Revenue |
(10)
|
(3)
|
(3)
|
0
|
(1)
|
(1)
|
(0)
|
0
|
(0)
|
(830)
|
(829)
|
(792)
|
|
| Gross Profit |
6
N/A
|
8
+21%
|
8
N/A
|
0
N/A
|
2
N/A
|
15
+589%
|
13
-15%
|
0
N/A
|
14
N/A
|
1 716
+12 054%
|
1 734
+1%
|
1 695
-2%
|
|
| Operating Income | |||||||||||||
| Operating Expenses |
(1 056)
|
(2 910)
|
(3 321)
|
(875)
|
(903)
|
(798)
|
(656)
|
(702)
|
(532)
|
(980)
|
(934)
|
(1 060)
|
|
| Selling, General & Administrative |
(182)
|
(239)
|
(384)
|
(303)
|
(309)
|
(215)
|
(143)
|
(130)
|
(100)
|
(866)
|
(852)
|
(822)
|
|
| Research & Development |
(748)
|
(660)
|
(932)
|
(569)
|
(636)
|
(574)
|
(514)
|
(555)
|
(449)
|
(122)
|
(82)
|
(163)
|
|
| Depreciation & Amortization |
0
|
(38)
|
0
|
(46)
|
0
|
(12)
|
0
|
(14)
|
(6)
|
(71)
|
(76)
|
(74)
|
|
| Other Operating Expenses |
(126)
|
(1 972)
|
(2 005)
|
43
|
42
|
3
|
1
|
(4)
|
23
|
79
|
77
|
(1)
|
|
| Operating Income |
(1 049)
N/A
|
(2 902)
-177%
|
(3 313)
-14%
|
(875)
+74%
|
(900)
-3%
|
(783)
+13%
|
(643)
+18%
|
(702)
-9%
|
(518)
+26%
|
736
N/A
|
801
+9%
|
635
-21%
|
|
| Pre-Tax Income | |||||||||||||
| Interest Income Expense |
(11)
|
(133)
|
(129)
|
10
|
31
|
50
|
44
|
34
|
17
|
(255)
|
(242)
|
(139)
|
|
| Non-Reccuring Items |
(0)
|
(1)
|
(1)
|
(0)
|
0
|
0
|
0
|
(9)
|
(28)
|
1
|
10
|
(1)
|
|
| Total Other Income |
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
0
|
|
| Pre-Tax Income |
(1 061)
N/A
|
(3 036)
-186%
|
(3 443)
-13%
|
(866)
+75%
|
(869)
0%
|
(732)
+16%
|
(599)
+18%
|
(677)
-13%
|
(529)
+22%
|
482
N/A
|
569
+18%
|
496
-13%
|
|
| Net Income | |||||||||||||
| Tax Provision |
4
|
6
|
10
|
1
|
(0)
|
2
|
1
|
2
|
2
|
(95)
|
(100)
|
(97)
|
|
| Income from Continuing Operations |
(1 057)
|
(3 031)
|
(3 433)
|
(865)
|
(869)
|
(730)
|
(599)
|
(675)
|
(526)
|
388
|
469
|
399
|
|
| Income to Minority Interest |
2
|
3
|
5
|
0
|
(1)
|
0
|
(0)
|
1
|
1
|
2
|
(0)
|
0
|
|
| Net Income (Common) |
(1 055)
N/A
|
(3 027)
-187%
|
(3 428)
-13%
|
(865)
+75%
|
(870)
-1%
|
(730)
+16%
|
(599)
+18%
|
(674)
-13%
|
(526)
+22%
|
388
N/A
|
468
+21%
|
399
-15%
|
|
| EPS (Diluted) |
-2.92
N/A
|
-12.36
-323%
|
-6.97
+44%
|
-1.75
+75%
|
-1.74
+1%
|
-1.45
+17%
|
-1.18
+19%
|
-1.33
-13%
|
-1.04
+22%
|
0.23
N/A
|
0.89
+287%
|
0.24
-73%
|
|
Switch to:
Switch to:
See Also
Discover More
